tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Technical Analysis

156 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
4Neutral
15Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Gain Therapeutics’s (GANX) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Gain Therapeutics is a Buy.
Gain Therapeutics’s (GANX) 20-Day exponential moving average is 2.39, while Gain Therapeutics’s (GANX) share price is $1.24, making it a Sell.
Gain Therapeutics’s (GANX) 50-Day exponential moving average is 2.78, while Gain Therapeutics’s (GANX) share price is $1.24, making it a Sell.

Gain Therapeutics (GANX) Pivot Points

Jun 15, 2024, 10:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.62
1.84
1.98
2.20
2.34
2.56
2.70
Fibonacci
1.84
1.98
2.07
2.20
2.34
2.43
2.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gain Therapeutics (GANX) Moving Averages

Jun 15, 2024, 10:38 AM
Period
Simple
Exponential
MA5
2.14Sell
2.13Sell
MA10
2.30Sell
2.24Sell
MA20
2.40Sell
2.39Sell
MA50
2.78Sell
2.78Sell
MA100
3.54Sell
3.12Sell
MA200
3.29Sell
3.27Sell
Gain Therapeutics’s (GANX) 10-Day exponential moving average is 2.24, while Gain Therapeutics’s (GANX) share price is $1.24, making it a Sell.
Gain Therapeutics’s (GANX) 100-Day exponential moving average is 3.12, while Gain Therapeutics’s (GANX) share price is $1.24, making it a Sell.
Gain Therapeutics’s (GANX) stock price is $1.24 and Gain Therapeutics’s (GANX) 50-day simple moving average is 2.78, creating a Sell signal.
Gain Therapeutics’s (GANX) stock price is $1.24 and Gain Therapeutics’s (GANX) 100-day simple moving average is 3.54, creating a Sell signal.
Gain Therapeutics’s (GANX) stock price is $1.24 and Gain Therapeutics’s (GANX) 200-day simple moving average is 3.29, creating a Sell signal.

Gain Therapeutics (GANX) Technical Indicators

Jun 15, 2024, 10:38 AM
Name
Value
Implied Action
RSI (14)
31.64
Neutral
STOCH (9,6)
23.22
Neutral
STOCHRSI (14)
21.90
Neutral
MACD (12,26)
-0.20
Buy
ADX (14)
22.86
Neutral
Williams %R
-91.57
Buy
CCI (14)
-247.70
Buy
ATR (14)
0.29
-
Ultimate Oscillator
29.82
Sell
ROC
-22.86
Sell
Gain Therapeutics’s (GANX) Relative Strength Index (RSI) is 31.64, creating a Neutral signal.
Gain Therapeutics’s (GANX) Trend Strength Indicator (ADX) is 22.86, creating a Neutral signal.
Gain Therapeutics’s (GANX) Commodity Channel Index (CCI) is -247.70, creating a Buy signal.
Gain Therapeutics’s (GANX) Price Rate of Change (ROC) is -22.86, creating a Sell signal.

FAQ

Is GANX a Buy, Hold, or Sell?
Based on GANX’s technical indicators, GANX is a Strong Sell.
    What is GANX’s RSI (14)?
    GANX’s RSI (14) is 31.64, which suggests GANX is a Neutral.
      What is GANX’s MACD?
      GANX’s MACD is -0.20, which suggests GANX is a Buy.
        What is GANX’s 5-day moving average?
        GANX’s 5-day moving average is 2.14, which suggests GANX is a Sell.
          What is GANX’s 20-day moving average?
          GANX 20-day moving average is 2.40, which suggests GANX is a Sell.
            What is GANX’s 50-day moving average?
            GANX’s 50-day moving average is 2.78, which suggests GANX is a Sell.
              What is GANX’s 200-day moving average?
              GANX’s 200-day moving average is 3.29, which suggests GANX is a Sell.
                What is GANX’s Williams % R (14)?
                GANX’s Williams % R (14) is -91.57, which suggests GANX is a Buy.
                  What is GANX’s CCI (14)?
                  GANX’s CCI (14) is -247.70, which suggests GANX is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis